title: Nephrogenic diabetes insipidus associated with foscarnet treatment of cytomegalovirus retinitis.
authors.affiliation: San Francisco General Hospital, California.
authors.forename: R V
authors.initials: RV
authors.lastname: Farese
authors.forename: M
authors.initials: M
authors.lastname: Schambelan
authors.forename: H
authors.initials: H
authors.lastname: Hollander
authors.forename: S
authors.initials: S
authors.lastname: Stringari
authors.forename: M A
authors.initials: MA
authors.lastname: Jacobson
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000188:drug therapy*; D003919:Diabetes Insipidus / Q000139:chemically induced*; D015828:Eye Infections, Viral / Q000188:drug therapy*; D017245:Foscarnet; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced; D008297:Male; D010746:Phosphonoacetic Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012173:Retinitis / Q000188:drug therapy* / Q000209:etiology
chemical_list: D000998:Antiviral Agents; D017245:Foscarnet; D010746:Phosphonoacetic Acid